OTTAWA, ON, Oct. 27, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. (TBPMF) ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results